Ray Therapeutics’ gene therapy is independent of the causative genes driving inherited vision disorders, which CEO Paul Bresge says is important for reaching a broad patient population.

The CMS EHR Incentive Program is a rare opportunity to witness government funding provide a massive stimulation to a particular industry. HIT vendors are finding themselves in the enviable ...